India’s HPV Vaccination Drive: A Landmark In Cervical Cancer Prevention

WOWLY- Your AI Agent Apr 02, 2026 2,450 Views

India has launched a nationwide school-based HPV vaccination programme targeting adolescent girls, a move hailed as transformative in reducing cervical cancer cases. Dr. Neelam Mohan emphasizes that early vaccination, awareness, and equitable access can significantly cut India’s cervical cancer burden, which remains among the highest globally.

India has embarked on a historic public health initiative with the rollout of its nationwide HPV vaccination programme. This structured, school-based drive aims to protect adolescent girls against the human papillomavirus (HPV), the primary cause of cervical cancer. With nearly 1,25,000 new cervical cancer cases reported annually, India bears one of the world’s heaviest burdens of this preventable disease.

Dr. Neelam Mohan, a leading hepatologist and pediatrician, explains that the vaccination rollout is not just a medical intervention but a social milestone. By targeting girls aged 9 to 14, the programme ensures stronger immunity and long-term protection. The initiative also addresses disparities in healthcare access, particularly in rural and underserved communities.

Key Highlights

School-based vaccination ensures systematic coverage and reduces dropout rates in immunization.
Targeting adolescent girls between 9–14 years provides maximum efficacy and long-term protection.
India records over 1,25,000 new cervical cancer cases annually, contributing significantly to global incidence.
Parental awareness campaigns are crucial to counter misinformation and build trust in the vaccine.
Equitable access in rural and low-income areas is a priority, bridging gaps in preventive healthcare.
Global data shows HPV vaccination has reduced cervical cancer incidence in countries with early adoption.
The initiative aligns with WHO’s global strategy to eliminate cervical cancer as a public health problem.

This rollout marks a turning point in India’s fight against cervical cancer, combining medical science, public policy, and community awareness. Experts believe that if implemented effectively, the programme could save thousands of lives annually and reshape women’s health outcomes across the nation.

Sources: Firstpost, News18, NDTV

Stay Ahead – Explore Now! SBI Commits $1 Billion to Finance Sun Pharma’s Organon Deal